In a new effort to push the abortion agenda in the United States, House Democrats are pushing the Food and Drug Administration (FDA) to remove restrictions on mifepristone, a drug commonly used to perform abortions in the first three months of pregnancy.

Current FDA policy requires women to obtain the first of two chemical abortion pills through a health care professional and not through telemedicine. The face-to-face requirement is intended to ensure that women receive the necessary monitoring and follow-up, according to National Review.

Safety requirements for mifepristone

The FDA’s parameters for providing the drug require that it be ordered, prescribed, and dispensed by or under the supervision of a health care provider. It also states access to treatment to clinics, doctors’ offices, and hospitals by or under the supervision of a licensed health care provider.

Several Democratic members of the House Oversight Committee sent a letter to FDA Acting Commissioner Janet Woodcock, on Feb. 9 demanding that the in-person dispensing requirement for the drug be immediately eliminated, deeming it “medically unnecessary.”

The Democrats seek to back up their request by arguing that “imposing this requirement in the midst of a deadly pandemic — one that has disproportionately impacted communities of color across the United States — needlessly places patients and providers in harm’s way, and further entrenches longstanding health inequities.”

Democrats and pro-abortion

As National Review noted, the missive is the latest move in efforts by Democratic lawmakers alongside pro-abortion groups to eliminate safety requirements for chemical abortion during the CCP (Chinese Communist Party) Virus pandemic, or COVID-19.

In March of last year, a coalition of Democratic attorneys general urged the FDA to remove the pandemic safety guidelines, and last summer, a federal judge called them a “substantial obstacle,” upholding the alleged right to abortion under pandemic conditions and imposed quarantines.

Under Joe Biden’s administration, plans to eradicate the pro-life laws and policies that Donald Trump’s administration worked for continue to move forward. 

Biden executive orders remove obstacle to federal funds for abortions

Within days of taking office, Biden signed an executive order to eliminate Trump’s signature Mexico City policy, which prohibited federal funds from going to nongovernment organizations that perform medical interventions to terminate pregnancies outside the United States.

In 2019, Biden came out in favor of repealing the Hyde Amendment, which prohibits the use of federal money for abortion services in most cases. He said, “I can’t justify leaving millions of women without access to the care they need and the ability … to exercise their constitutional protected right.”

However, peer-reviewed studies have shown that more than 2 million people are alive today in the United States because of the Hyde Amendment, with approximately 60,000 children not dying from abortion each year.

2 million lives saved

This means that more than 2 million people who would have been aborted survived, since funds were not available to end the lives of the unborn, being earmarked instead for prenatal care for the mothers.

Regarding chemical abortions, reports have shown that there is currently an increase in this practice relative to the overall abortion rate in the United States. A report from the National Review, explains that since the FDA first approved mifepristone for abortions in 2000, there has been a steady increase in chemical abortions.

Chemical abortions on the increase

“Between 2015 and 2018, the percentage of total abortions that were chemical abortions increased from 25 percent to 40 percent,” the report states. “Among the 42 states that reported data on type of procedure in both 2017 and 2018, the number of chemical abortions increased by more than 10 percent.”

The increase in the number of chemical abortions is one of the main reasons why the Centers for Disease Control recorded a rare increase in the overall abortion rate in 2018, despite the fact that historically the U.S. abortion rate has declined significantly since 1980.

Meanwhile, the Democrats’ campaign to guarantee chemical abortion ignores the risks to women taking mifepristone treatment especially without adequate supervision or access to follow-up care, ignoring the drug’s potential side effects and complications that require specialized assistance.